Login  /  Register  | 3 premium articles left before you must register.

Pfizer invests $8 million in start-up

Published November 29. 2012 4:00AM

A Boston start-up developing drugs targeting diabetes and obesity got a big infusion of capital from Pfizer Inc. this week.

Pfizer Venture Investments backed Rhythm Pharma with $8 million, joining other venture capitalists such as MPM Capital, Third Rock Ventures and New Enterprise Associates as backers, according to a report on the website FiercePharma.

The company's two drugs in development are still likely years from approval. But the company, led by Keith Gottesdiener, formerly of Merck, has raised $73 million in two years. "We are pleased to help Rhythm capitalize on its opportunities," said Pfizer's Barbara Dalton, vice president of venture capital.

News by Town

Most Recent Poll
The 'grinding' dance style has sparked controversy at East Lyme High School. Should this form of dancing be banned at school dances?
Yes, it's highly suggestive and inappropriate at a school function.
No, teens will be teens. A ban would just encourage them more.
What's grinding? The Charleston is the last dance I learned.
Number of votes: 1118

No current items found